VLSM analysis of 350 meningioma resections links tumor location to histology, symptoms, and surgical outcomes
Brain tumor location patterns linked to symptoms and surgical outcomes in study
A retrospective, single-center cohort of 350 patients who underwent meningioma resection found that voxel-based lesion symptom mapping (VLSM…
Brain tumor location in the brain is linked to specific symptoms and how well surgery removes the growth, according to a new study.
Feasibility trial shows ePRO-led survivorship care may improve symptoms in early-stage cancer patients
Digital symptom tracking shows promise for cancer survivors in early trial
A feasibility RCT of 200 women with early-stage breast or gynecologic cancer tested a 12-month ePRO-led multidisciplinary intervention versu…
A digital health program helped recent cancer survivors in Ireland report less fatigue, anxiety, and depression while improving their qualit…
Corticosteroid therapy associated with greater weight loss and poorer appetite in advanced pancreatic cancer
Corticosteroid therapy linked to more weight loss in advanced pancreatic cancer patients
A post hoc analysis of the MISTRAL trial in 244 patients with advanced pancreatic cancer found corticosteroid therapy was associated with gr…
Corticosteroid therapy linked to more weight loss in advanced pancreatic cancer patients, who also reported less appetite and lower BMI duri…
Meta-analysis: Preoperative calcitonin predicts lateral cervical lymph node metastasis in medullary thyroid carcinoma
Can a simple blood test help surgeons plan thyroid cancer operations?
A meta-analysis of 8 studies (951 patients) with medullary thyroid carcinoma found preoperative serum calcitonin demonstrated good diagnosti…
A simple blood test measuring calcitonin levels can accurately predict if medullary thyroid cancer has spread to neck lymph nodes before sur…
Review summarizes molecular pathways and treatment options for Adult T-cell leukemia/lymphoma
What helps patients with a rare, aggressive blood cancer?
A systematic review summarizes the molecular pathogenesis and treatment landscape for Adult T-cell leukemia/lymphoma (ATLL).
For patients with rare, aggressive Adult T-cell leukemia/lymphoma, a drug called mogamulizumab shows promise when standard treatments fail.
Survey finds 67% of U.S. adults aged 50-75 met colorectal cancer screening recommendations
Survey finds about two-thirds of eligible U.S. adults are up to date on colon cancer screening
A 2018 observational survey of U.S. adults aged 50-75 found 67.0% met USPSTF colorectal cancer screening recommendations, and 60.6% reported…
About two-thirds of eligible U.S. adults aged 50 to 75 were up to date on colon cancer screening, yet a gap remains for many people.
Survey examines colonoscopy utilization among U.S. adults aged 50-75 without colorectal cancer history
Survey examines colonoscopy use among U.S. adults recommended for screening
An observational survey report assessed colonoscopy utilization in the past 10 years among U.S.
A new survey tracks how many U.S. adults aged 50 to 75 without colorectal cancer had a colonoscopy for screening in the last decade.
Observational study examines cancer death rates by urban-rural status in US population
Do cancer death rates differ between cities and rural areas?
An observational analysis of US National Vital Statistics System data from 1999-2019 examined age-adjusted cancer death rates by urban-rural…
Where you live might play a role in cancer risk, so a new analysis maps death rates across urban and rural areas for men and women over twen…
Report describes COVID-19 deaths among US cancer survivors in 2021
How many cancer survivors died with COVID-19 listed as a cause in 2021?
A descriptive report examined deaths among cancer survivors in the United States during 2021 where COVID-19 was listed as an underlying caus…
A 2021 report confirms COVID-19 was a documented cause of death for some cancer survivors, though it lacks specific numbers or comparisons t…
Phase 1 trial of WVT078 with/without WHG626 shows preliminary activity in relapsed/refractory multiple myeloma
Can a new combination therapy help when multiple myeloma returns?
A phase 1 dose-escalation trial in 56 patients with relapsed/refractory multiple myeloma assessed the BCMA×CD3 bispecific antibody WVT078 al…
Adding a second drug to a new antibody therapy nearly doubled response rates in early trials for patients with returning multiple myeloma.
Phase II trial opens for Viscum album extract adjuvant therapy in relapsed osteosarcoma
Early study explores mistletoe extract as additional treatment for relapsed bone cancer in young people
A Phase II trial is now open to evaluate adjuvant Viscum album extract (Iscador® P) in children and AYAs with relapsed, resectable osteosarc…
A pilot study found that adding mistletoe extract after surgery helped 55% of young people with relapsed bone cancer stay alive without dise…
CDSS Dashboard Implementation Associated with Higher CRPC Detection in Prostate Cancer Cohort
Can a digital dashboard help doctors spot prostate cancer progression sooner?
A retrospective single-centre cohort study of prostate cancer patients on ADT found that implementing a Clinical Decision Support System das…
A digital dashboard helped doctors spot prostate cancer progression sooner and catch unstable warning signs in patients already on hormone t…